Abstract
Observational studies have indicated that high blood pressure (BP) may be a risk factor to frailty. However, the causal association between BP and frailty remains not well determined. The purpose of this bi-directional two-sample Mendelian randomization (MR) study was to investigate the causal relationship between BP and frailty. Independent single nucleotide polymorphisms (SNPs) strongly (P < 5E-08) associated with systolic BP (SBP), diastolic BP (DBP), and pulse pressure (PP) were selected as instrumental variables. Two different published genome-wide association studies (GWAS) on BP from the CHARGE (n = 810,865) and ICBP (n = 757,601) consortia were included. Summary-level data on frailty index (FI) were obtained from the latest GWAS based on UK Biobank and Swedish TwinGene cohorts (n = 175,226). Inverse variance weighted (IVW) approach with other sensitivity analyses were used to calculate the causal estimate. Using the CHARGE dataset, genetic predisposition to increased SBP (β = 0.135, 95% CI = 0.093 to 0.176, P = 1.73E-10), DBP (β = 0.145, 95% CI = 0.104 to 0.186, P = 3.14E-12), and PP (β = 0.114, 95% CI = 0.070 to 0.157, p = 2.87E-07) contributed to a higher FI, which was validated in the ICBP dataset. There was no significant causal effect of FI on SBP, DBP, and PP. Similar results were obtained from different MR methods, indicating good stability. There was potential heterogeneity detected by Cochran’s Q test, but no horizontal pleiotropy was observed in MR-Egger intercept test (P > 0.05). These findings evinced that higher BP and PP were causally associated with an increased risk of frailty, suggesting that controlling hypertension could reduce the risk of frailty.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Data availability
The GWAS summary statistics data used in this MR study are all publicly available in GWAS Catalog (https://www.ebi.ac.uk/gwas/home).
Code availability
This paper does not report the original code.
References
Cohen CI, Benyaminov R, Rahman M, Ngu D, Reinhardt M. Frailty: a multidimensional biopsychosocial syndrome. Med Clin N Am. 2023;107:183–97.
de Breij S, van Hout HPJ, de Bruin SR, Schuster NA, Deeg DJH, Huisman M, et al. Predictors of frailty and vitality in older adults aged 75 years and over: results from the longitudinal aging study Amsterdam. Gerontology. 2021;67:69–77.
Atkins JL, Jylhävä J, Pedersen NL, Magnusson PK, Lu Y, Wang Y, et al. A genome-wide association study of the frailty index highlights brain pathways in ageing. Aging Cell. 2021;20:e13459.
Zhang XM, Cao S, Gao M, Xiao S, Xie X, Wu X. The prevalence of social frailty among older adults: a systematic review and meta-analysis. J Am Med Dir Assoc. 2023;24:29–37.e9.
Li J, Chen H, He W, Luo L, Guo X. Frailty index and risk of cardiovascular diseases: a Mendelian randomization study. Ann Transl Med. 2022;10:1007.
Pérez-Sáez MJ, Gutiérrez-Dalmau Á, Moreso F, Rodríguez-Mañas L, Pascual J. Frailty and kidney transplant candidates. Nefrologia. 2021;41:237–43.
Zheng Z, Lv Y, Rong S, Sun T, Chen L. Physical frailty, genetic predisposition, and incident Parkinson disease. JAMA Neurol. 2023;80:455–61.
Proietti M, Romiti GF, Vitolo M, Harrison SL, Lane DA, Fauchier L, et al. Epidemiology and impact of frailty in patients with atrial fibrillation in Europe. Age Ageing. 2022;51:afac192.
Myers MG, Godwin M. Automated office blood pressure. Can J Cardiol. 2012;28:341–6.
Lu J, Lu Y, Wang X, Li X, Linderman GC, Wu C, et al. Prevalence, awareness, treatment, and control of hypertension in China: data from 1·7 million adults in a population-based screening study (China PEACE Million Persons Project). Lancet. 2017;390:2549–58.
Karayiannis CC. Hypertension in the older person: is age just a number? Intern Med J. 2022;52:1877–83.
Zhu Y, Chen X, Geng S, Li Q, Yuan H, Zhou X, et al. Association between ambulatory blood pressure variability and frailty among older hypertensive patients. J Clin Hypertens. 2020;22:1703–12.
Shen F, Chen J, Yang R, Yang J, Li H. Association between control status of blood pressure and frailty among middle-aged and older adults with hypertension in China: a longitudinal study. BMJ Open. 2022;12:e056395.
Wang Z, Du X, Hua C, Li W, Zhang H, Liu X, et al. The effect of frailty on the efficacy and safety of intensive blood pressure control: a post hoc analysis of the SPRINT trial. Circulation. 2023;148:565–74.
Coelho-Junior HJ, Uchida MC, Picca A, Calvani R, Landi F, de Oliveira Gonçalves I, et al. Frailty is not associated with hypertension, blood pressure or antihypertensive medication in community-dwelling older adults: a cross-sectional comparison across 3 frailty instruments. Exp Gerontol. 2021;146:111245.
Lawlor DA, Harbord RM, Sterne JA, Timpson N, Davey Smith G. Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Stat Med. 2008;27:1133–63.
Zhang N, Jia Z, Gu T, Zheng Y, Zhang Y, Song W, et al. Associations between modifiable risk factors and frailty: a Mendelian randomisation study. J Epidemiol Community Health. 2023;77:782–90.
Surendran P, Feofanova EV, Lahrouchi N, Ntalla I, Karthikeyan S, Cook J, et al. Discovery of rare variants associated with blood pressure regulation through meta-analysis of 1.3 million individuals. Nat Genet. 2020;52:1314–32.
Evangelou E, Warren HR, Mosen-Ansorena D, Mifsud B, Pazoki R, Gao H, et al. Genetic analysis of over 1 million people identifies 535 new loci associated with blood pressure traits. Nat Genet. 2018;50:1412–25.
Sanderson E, Glymour MM, Holmes MV, Kang H, Morrison J, Munafò MR, et al. Mendelian randomization. Nat Rev Methods Prim. 2022;2:6.
Hemani G, Zheng J, Elsworth B, Wade KH, Haberland V, Baird D, et al. The MR-Base platform supports systematic causal inference across the human phenome. Elife. 2018;7:e34408.
Burgess S, Butterworth A, Thompson SG. Mendelian randomization analysis with multiple genetic variants using summarized data. Genet Epidemiol. 2013;37:658–65.
Verbanck M, Chen CY, Neale B, Do R. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat Genet. 2018;50:693–8.
Guo X, Tang P, Zhang L, Li R. Tobacco and alcohol consumption and the risk of frailty and falling: a Mendelian randomisation study. J Epidemiol Community Health. 2023;77:349–54.
Masoli JAH, Delgado J. Blood pressure, frailty and dementia. Exp Gerontol. 2021;155:111557.
Forouzanfar MH, Liu P, Roth GA, Ng M, Biryukov S, Marczak L, et al. Global burden of hypertension and systolic blood pressure of at least 110 to 115 mm Hg, 1990-2015. JAMA. 2017;317:165–82.
Woo J, Yu R, Tsoi K, Meng H. Variability in repeated blood pressure measurements as a marker of frailty. J Nutr Health Aging. 2018;22:1122–7.
Gu Y, Wan Y, Ren JH, Zhao Y, Wang Y, Shen JH. Analysis of systolic and diastolic blood pressure variability in frail, pre-frail, and non-frail elderly patients: The relationship between frailty syndrome and blood pressure variability in the elderly. Medicine. 2023;102:e32874.
Rouch L, De Souto Barreto P, Hanon O, Vidal JS, Amar J, Andrieu S, et al. Visit-to-visit blood pressure variability and incident frailty in older adults. J Gerontol A Biol Sci Med Sci. 2021;76:1369–75.
Anker D, Carmeli C, Zwahlen M, Rodondi N, Santschi V, Henchoz Y, et al. How blood pressure predicts frailty transitions in older adults in a population-based cohort study: a multi-state transition model. Int J Epidemiol. 2022;51:1167–77.
Ishikawa J, Toba A, Tamura Y, Araki A, Harada K. Changes in blood pressure associated with frailty and sarcopenia in elderly outpatients with cardiometabolic diseases. Geriatr Gerontol Int. 2023;23:506–16.
Chae CU, Lee RT, Rifai N, Ridker PM. Blood pressure and inflammation in apparently healthy men. Hypertension. 2001;38:399–403.
Bautista LE, Vera LM, Arenas IA, Gamarra G. Independent association between inflammatory markers (C-reactive protein, interleukin-6, and TNF-alpha) and essential hypertension. J Hum Hypertens. 2005;19:149–54.
Mourtzi N, Georgakis M, Ntanasi E, Hatzimanolis A, Ramirez A, Heilmann-Heimbach S, et al. Genetically downregulated Interleukin-6 signalling is associated with a lower risk of frailty. Age Ageing. 2023;52:afac318.
Butt JH, Dewan P, Jhund PS, Anand IS, Atar D, Ge J, et al. Sacubitril/valsartan and frailty in patients with heart failure and preserved ejection fraction. J Am Coll Cardiol. 2022;80:1130–43.
Acknowledgements
The authors acknowledge all the participants, researchers, and consortia who contributed to this study.
Author information
Authors and Affiliations
Contributions
GT, XG, and RL conceived and designed the study. GT, RZ, and XG collected and analyzed the data. GT and RZ drafted the manuscript. XG and RL revised the manuscript. All authors reviewed and approved the final manuscript.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Ethical approval
This study was performed based on publicly available data and no separate ethical approval and consent was required.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Tian, G., Zhou, R., Guo, X. et al. Causal effects of blood pressure and the risk of frailty: a bi-directional two-sample Mendelian randomization study. J Hum Hypertens 38, 329–335 (2024). https://doi.org/10.1038/s41371-024-00901-w
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41371-024-00901-w